Your browser doesn't support javascript.
loading
Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
Eadie, James A; Ip, Michael S; Kulkarni, Amol D.
Affiliation
  • Eadie JA; Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisonsin.
Retina ; 34(12): 2439-43, 2014 Dec.
Article in En | MEDLINE | ID: mdl-24999721
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Retinal Vein Occlusion / Macular Edema / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Vascular Endothelial Growth Factor A / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Recombinant Fusion Proteins / Retinal Vein Occlusion / Macular Edema / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Vascular Endothelial Growth Factor A / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article